Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Kidney Cancer
• Ureter Cancer
• Urothelial Carcinoma

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Urothelial Carcinoma, Kidney Cancer | Phase 2 | Status: COMPLETED